Related references
Note: Only part of the references are listed.Psychometric properties of the EQ-5D-5L: a systematic review of the literature
You-Shan Feng et al.
QUALITY OF LIFE RESEARCH (2021)
A randomized, double-blind study comparing the efficacy and safety of trazodone once-a-day and venlafaxine extended-release for the treatment of patients with major depressive disorder
Andrea Fagiolini et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2020)
Weight gain and associated factors in patients using newer antidepressant drugs
Faruk Uguz et al.
GENERAL HOSPITAL PSYCHIATRY (2015)
Major depressive disorder: mechanism-based prescribing for personalized medicine
Philip F. Saltiel et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2015)
Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study
M. F. Janssen et al.
QUALITY OF LIFE RESEARCH (2013)
Rediscovering Trazodone for the Treatment of Major Depressive Disorder
Andrea Fagiolini et al.
CNS DRUGS (2012)
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
M. Herdman et al.
QUALITY OF LIFE RESEARCH (2011)
Mechanism of Action of Trazodone: a Multifunctional Drug
Stephen M. Stahl
CNS SPECTRUMS (2009)
Resolution of sleepiness and fatigue in major depressive disorder: A comparison of bupropion and the selective serotonin reuntake inhibitors
George I. Papakostas et al.
BIOLOGICAL PSYCHIATRY (2006)
A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder
C. Munizza et al.
CURRENT MEDICAL RESEARCH AND OPINION (2006)
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice
MH Trivedi et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Antidepressant-related adverse effects impacting treatment compliance: Results of a patient survey
AK Ashton et al.
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL (2005)
Psychosocial impairment and recurrence of major depression
DA Solomon et al.
COMPREHENSIVE PSYCHIATRY (2004)
Onset of action of antidepressants: results of different analyses
C Thompson
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2002)
Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia
M Fava et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2002)
Prevalence of sexual dysfunction among newer antidepressants
AH Clayton et al.
JOURNAL OF CLINICAL PSYCHIATRY (2002)
Treatment of men with major depression: A comparison of sequential cohorts treated with either cognitive-behavioral therapy or newer generation antidepressants
ME Thase et al.
JOURNAL OF CLINICAL PSYCHIATRY (2000)
Share Paper
